Tim Mandelkow

507 total citations
6 papers, 15 citations indexed

About

Tim Mandelkow is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Tim Mandelkow has authored 6 papers receiving a total of 15 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Tim Mandelkow's work include Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (2 papers) and Immunotherapy and Immune Responses (2 papers). Tim Mandelkow is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (2 papers) and Immunotherapy and Immune Responses (2 papers). Tim Mandelkow collaborates with scholars based in Germany. Tim Mandelkow's co-authors include Sören Weidemann, Till S. Clauditz, Roland Dahlem, Niclas C. Blessin, Silke Riechardt, Franziska Büscheck, Katharina Möller, Ronald Simon, Margit Fisch and Till Eichenauer and has published in prestigious journals such as Cancer Research, American Journal of Clinical Pathology and Cancers.

In The Last Decade

Tim Mandelkow

4 papers receiving 14 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Mandelkow Germany 2 12 7 5 5 2 6 15
Ariana Hardy United States 2 15 1.3× 6 0.9× 5 1.0× 4 0.8× 2 1.0× 4 29
Havish S. Kantheti United States 2 12 1.0× 5 0.7× 5 1.0× 4 0.8× 2 1.0× 2 19
Kristian Haendler Germany 3 14 1.2× 10 1.4× 6 1.2× 10 2.0× 2 1.0× 3 31
Daisy D. Colón-López United States 3 19 1.6× 5 0.7× 3 0.6× 4 0.8× 4 32
Norain Ab. Latif Malaysia 3 7 0.6× 8 1.1× 7 1.4× 3 0.6× 1 0.5× 4 23
Nancy Roche United States 2 9 0.8× 4 0.6× 5 1.0× 2 0.4× 2 1.0× 5 21
Russell Kunes United States 2 22 1.8× 5 0.7× 4 0.8× 5 1.0× 4 36
Julia E. Rudolph United States 4 10 0.8× 6 0.9× 7 1.4× 6 1.2× 7 22
N Egoroff Australia 2 8 0.7× 9 1.3× 3 0.6× 7 1.4× 2 1.0× 2 23
Nils Rouven Hansmeier Germany 4 9 0.8× 8 1.1× 3 0.6× 3 0.6× 3 1.5× 5 27

Countries citing papers authored by Tim Mandelkow

Since Specialization
Citations

This map shows the geographic impact of Tim Mandelkow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Mandelkow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Mandelkow more than expected).

Fields of papers citing papers by Tim Mandelkow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Mandelkow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Mandelkow. The network helps show where Tim Mandelkow may publish in the future.

Co-authorship network of co-authors of Tim Mandelkow

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Mandelkow. A scholar is included among the top collaborators of Tim Mandelkow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Mandelkow. Tim Mandelkow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Mandelkow, Tim, Guido Sauter, Niclas C. Blessin, et al.. (2023). Intraepithelial CD8+ cytotoxic T-cells are the main component of the immune tumor microenvironment that drive prognosis in muscle-invasive bladder cancer. American Journal of Clinical Pathology. 160(Supplement_1). S45–S46.
2.
Möller, Katharina, Tim Mandelkow, Ronald Simon, et al.. (2022). Abstract 597: BLEACH&STAIN 15 marker multiplexed imaging in 3098 human carcinomas revealed six major PD-L1 driven immune phenotypes with distinct spatial orchestration. Cancer Research. 82(12_Supplement). 597–597. 1 indexed citations
3.
Burandt, Eike, Niclas C. Blessin, Florian Lutz, et al.. (2022). T-Cell Density at the Invasive Margin and Immune Phenotypes Predict Outcome in Vulvar Squamous Cell Cancer. Cancers. 14(17). 4246–4246. 3 indexed citations
4.
Dum, David, Niclas C. Blessin, Tim Mandelkow, et al.. (2021). Semi-automated validation and quantification of CTLA-4 in 90 different Tumor entities using multiple antibodies and artificial intelligence. American Journal of Clinical Pathology. 156(Supplement_1). S137–S138. 1 indexed citations
5.
Eichenauer, Till, Christoph Fraune, Tim Mandelkow, et al.. (2020). High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma. World Journal of Urology. 39(2). 481–490. 10 indexed citations
6.
Blessin, Niclas C., Ronald Simon, Martina Kluth, et al.. (2018). Abstract 696: Patterns of TIGIT expression in normal lymphatic tissue, inflammation and cancer. Cancer Research. 78(13_Supplement). 696–696.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026